Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced α9-nicotinic acetylcholine receptor upregulation in human breast cancer cells

Molecular Nutrition and Food Research

Volumn 55, Issue 3, 2011, Pages 455-466

  Tu, Shih Hsin ^a,b   Ku, Chung Yu ^c   Ho, Chi Tang ^d   Chen, Ching Shyang ^b   Huang, Ching Shui ^a,b   Lee, Chia Hwa ^c   Chen, Li Ching ^c   Pan, Min Hsiung ^e   Chang, Hui Wen ^f   Chang, Chien Hsi ^f   Chang, Yu Jia ^b,g   Wei, Po Li ^b,g   Wu, Chih Hsiung ^b,g   Ho, Yuan Soon ^c,f,g  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d RUTGERS UNIVERSITY   (United States)

^e NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

( ) Epigallocatechin 3 gallate; Breast cancer; Estradiol; Nicotine; Nicotinic acetylcholine receptor

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; ESTROGEN; FLAVONOID; MESSENGER RNA; NACHR ALPHA9; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PHENOL DERIVATIVE; POLYPHENOLS;

ARTICLE; CELL PROLIFERATION; CHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; TEA; TUMOR CELL LINE; UPREGULATION;

ANTINEOPLASTIC AGENTS, HORMONAL; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; ESTROGENS; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NICOTINE; NICOTINIC ANTAGONISTS; PHENOLS; RECEPTORS, NICOTINIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; TEA; UP-REGULATION;

EID: 79952124971     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000254     Document Type: Article

References (41)

1. Lin, Y., Kikuchi, S., Tamakoshi, K., Wakai, K. et al., Active smoking, passive smoking, and breast cancer risk: findings from the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. J. Epidemiol. 2008, 18, 77-83.
2. Slattery, M. L., Curtin, K., Giuliano, A. R., Sweeney, C. et al., Active and passive smoking, IL6, ESR1, and breast cancer risk. Breast Cancer Res. Treat. 2008, 109, 101-111.
3. Armitage, A. K., Dollery, C. T., George, C. F., Houseman, T. H. et al., Absorption and metabolism of nicotine from cigarettes. Br. Med. J. 1975, 4, 313-316.
4. Benowitz, N. L., Jacob, P., 3rd, Nicotine and carbon monoxide intake from high- and low-yield cigarettes. Clin. Pharmacol. Ther. 1984, 36, 265-270.
5. Lindell, G., Farnebo, L. O., Chen, D., Nexo, E. et al., Acute effects of smoking during modified sham feeding in duodenal ulcer patients. An analysis of nicotine, acid secretion, gastrin, catecholamines, epidermal growth factor, prostaglandin E2, and bile acids. Scand. J. Gastroenterol. 1993, 28, 487-494.
6. Mei, J., Hu, H., McEntee, M., Plummer, H., 3rd et al., Transformation of non-cancerous human breast epithelial cell line MCF10A by the tobacco-specific carcinogen NNK. Breast Cancer Res. Treat. 2003, 79, 95-105.
7. Siriwardhana, N., Choudhary, S., Wang, H. C., Precancerous model of human breast epithelial cells induced by NNK for prevention. Breast Cancer Res. Treat. 2008, 109, 427-441.
8. Heeschen, C., Jang, J. J., Weis, M., Pathak, A. et al., Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat. Med. 2001, 7, 833-839.
9. Kellar, K. J., Davila-Garcia, M. I., Xiao, Y., Pharmacology of neuronal nicotinic acetylcholine recceptors: effects of acute and chronic nicotine. Nicotine Tob. Res. 1999, 1, S117-S120; discussion S139-S140.
10. Schuller, H. M., Orloff, M., Tobacco-specific carcinogenic nitrosamines. Ligands for nicotinic acetylcholine receptors in human lung cancer cells. Biochem. Pharmacol. 1998, 55, 1377-1384.
11. Ho, Y. S., Chen, C. H., Wang, Y. J., Pestell, R. G. et al., Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation. Toxicol. Appl. Pharmacol. 2005, 205, 133-148.
12. Wei, P. L., Chang, Y. J., Ho, Y. S., Lee, C. H. et al., Tobacco-specific carcinogen enhances colon cancer cell migration through alpha7-nicotinic acetylcholine receptor. Ann. Surg. 2009, 249, 978-985.
13. Chen, R. J., Ho, Y. S., Guo, H. R., Wang, Y. J., Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells. Toxicol. Sci. 2008, 104, 283-293.
14. Chen, C. S., Lee, C. H., Hsieh, C. D., Ho, C. T. et al., Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins. Breast Cancer Res. Treat. 2010, in press, DOI: 10.1007/s10549-010-0821-3.
15. Shih, Y. L., Liu, H. C., Chen, C. S., Hsu, C. H. et al., Combination treatment with luteolin and quercetin enhances antiproliferative effects in nicotine-treated MDA-MB-231 cells by down-regulating nicotinic acetylcholine receptors. J. Agric. Food Chem. 2010, 58, 235-241.
16. Lin, Y. S., Tsai, Y. J., Tsay, J. S., Lin, J. K., Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J. Agric. Food Chem. 2003, 51, 1864-1873.
17. Lin, J. K., Chen, P. C., Ho, C. T., Lin-Shiau, S. Y., Inhibition of xanthine oxidase and suppression of intracellular reactive oxygen species in HL-60 cells by theaflavin-3, 3'-digallate, (-)-epigallocatechin-3-gallate, and propyl gallate. J. Agric. Food Chem. 2000, 48, 2736-2743.
18. Pan, M. H., Lin, C. C., Lin, J. K., Chen, W. J., Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling. J. Agric. Food Chem. 2007, 55, 5030-5037.
19. Stuart, E. C., Rosengren, R. J., The combination of raloxifene and epigallocatechin gallate suppresses growth and induces apoptosis in MDA-MB-231 cells. Life Sci. 2008, 82, 943-948.
20. Butt, M. S., Sultan, M. T., Green tea: nature's defense against malignancies. Crit. Rev. Food Sci. Nutr. 2009, 49, 463-473.
21. Pan, M. H., Huang, M. C., Wang, Y. J., Lin, J. K., Lin, C. H., Induction of apoptosis by hydroxydibenzoylmethane through coordinative modulation of cyclin D3, Bcl-X(L), and Bax, release of cytochrome c, and sequential activation of caspases in human colorectal carcinoma cells. J. Agric. Food Chem. 2003, 51, 3977-3984.
22. Chen, L. C., Liu, Y. C., Liang, Y. C., Ho, Y. S., Lee, W. S., Magnolol inhibits human glioblastoma cell proliferation through upregulation of p21/Cip1. J. Agric. Food Chem. 2009, 57, 7331-7337.
23. Daniell, H. W., Estrogen receptors, breast cancer, and smoking. N. Engl. J. Med. 1980, 302, 1478.
24. Aggarwal, B. B., Sethi, G., Ahn, K. S., Sandur, S. K. et al., Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann. NY Acad. Sci. 2006, 1091, 151-169.
25. Liu, Z., Yu, X., Shaikh, Z. A., Rapid activation of ERK1/2 and AKT in human breast cancer cells by cadmium. Toxicol. Appl. Pharmacol. 2008, 228, 286-294.
26. Lee, C. H., Huang, C. S., Chen, C. S., Tu, S. H. et al., Overexpression and activation of the α9-nicotinic receptor during tumorigenesis in human breast epithelial cells. J. Natl. Cancer Inst. 2010, 102, 1322-1335.
27. West, K. A., Brognard, J., Clark, A. S., Linnoila, I. R. et al., Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J. Clin. Invest. 2003, 111, 81-90.
28. Iwasaki, M., Inoue, M., Sasazuki, S., Miura, T. et al., Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case-control study. Breast Cancer Res. Treat. 2010, in press, DOI: 10.1007/s10549-010-0916-x.
29. Nakachi, K., Suemasu, K., Suga, K., Takeo, T. et al., Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res. 1998, 89, 254-261.
30. Luo, T., Wang, J., Yin, Y., Hua, H. et al., (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Breast Cancer Res. 2010, 12, R8.
31. Weisburger, J. H., Chung, F. L., Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. Food Chem. Toxicol. 2002, 40, 1145-1154.
32. Sun, X., Ritzenthaler, J. D., Zhong, X., Zheng, Y. et al., Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha. Cancer Res. 2009, 69, 6445-6453.
33. Hsuuw, Y. D., Chan, W. H., Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells. Ann. NY Acad. Sci. 2007, 1095, 428-440.
34. Lin, J. K., Lin-Shiau, S. Y., Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol. Nutr. Food Res. 2006, 50, 211-217.
35. Lin, J. K., Liang, Y. C., Lin-Shiau, S. Y., Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem. Pharmacol. 1999, 58, 911-915.
36. Lee, Y. R., Park, J., Yu, H. N., Kim, J. S. et al., Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells. Biochem. Biophys. Res. Commun. 2005, 336, 1221-1226.
37. Likhite, V. S., Stossi, F., Kim, K., Katzenellenbogen, B. S., Katzenellenbogen, J. A., Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity. Mol. Endocrinol. 2006, 20, 3120-3132.
38. Thomas, R. S., Sarwar, N., Phoenix, F., Coombes, R. C., Ali, S., Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity. J. Mol. Endocrinol. 2008, 40, 173-184.
39. Chen, D., Washbrook, E., Sarwar, N., Bates, G. J. et al., Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera. Oncogene 2002, 21, 4921-4931.
40. Pasapera Limon, A. M., Herrera-Munoz, J., Gutierrez-Sagal, R., Ulloa-Aguirre, A., The phosphatidylinositol 3-kinase inhibitor LY294002 binds the estrogen receptor and inhibits 17beta-estradiol-induced transcriptional activity of an estrogen sensitive reporter gene. Mol. Cell. Endocrinol. 2003, 200, 199-202.
41. Yamashita, H., Nishio, M., Toyama, T., Sugiura, H. et al., Low phosphorylation of estrogen receptor alpha (ERalpha) serine 118 and high phosphorylation of ERalpha serine 167 improve survival in ER-positive breast cancer. Endocr. Relat. Cancer 2008, 15, 755-763.